The human diet contains a wide variety of plant-derived flavonoids, many of which are glycosylated via an O-or less commonly a C-glycosidic linkage. The distribution, quantity, and biological effects of C-glycosyl flavonoids in the human diet have received little attention in the literature in comparison to their O-linked counterparts, however, despite being present in many common foodstuffs. The structural nature, nomenclature, and distribution of C-glycosyl flavonoids in the human diet are, therefore, reviewed. Forty-three dietary flavonoids are revealed to be C-glycosylated, arising from the dihydrochalcone, flavone, and flavan-3-ol backbones, and distributed among edible fruits, cereals, leaves, and stems. C-linked sugar groups are shown to include arabinose, galactose, glucose, rutinose, and xylose, often being present more than once on a single flavonoid backbone and occasionally in tandem with O-linked glucose or rutinose groups. The pharmacokinetic fate of these compounds is discussed with particular reference to their apparent lack of interaction with hydrolytic mechanisms known to influence the fate of O-glycosylated dietary flavonoids, explaining the unusual but potentially important appearance of intact Cglycosylated flavonoid metabolites in human urine following oral administration. Finally, the potential biological significance of these compounds is reviewed, describing mechanisms of antidiabetic, antiinflammatory, anxiolytic, antispasmodic, and hepatoprotective effects.
INTRODUCTION: C-GLYCOSYLATION OF FLAVONOIDS
The flavonoids are a highly diverse class of polyphenolic organic compounds formed principally as secondary plant metabolites with broad functional roles in planta, acting as siderophores, colorants, antioxidants, and attractants, while providing protection against UV-radiation, insects, fungi, and bacteria (Franz and Grun, 1983) . Their wide distribution throughout the plant kingdom results in their inevitable presence in diets rich in plant-derived foods or beverages, where they appear to contribute to the overall health benefits of consuming such a diet. The epidemiological link of flavonoid intake to prevention of diabetes appears to be the strongest thus far (Nicolle et al., 2011) , however, specific links of flavonoid intake to cardiovascular mortality, chronic inflammation, cancer, and other conditions are also evident (Steinmetz and Potter, 1996; Hirvonen et al., 2000; Manthey, 2000; Mink et al., 2007; Arab and Liebeskind, 2010) .
The flavonoid family tree begins with seven heterocyclic backbone families differentiated by fundamental structural features usually related to the C-ring, such as its presence, carbon saturation and position of B-ring bonding (Tomás- Barberán and Clifford, 2000) . These backbones are the flavan-3-ols, flavonols, flavones, flavanones, isoflavones, anthocyanidins, and chalcones (Scalbert and Williamson, 2000) , which are subsequently differentiated by the presence of functional moieties such as hydroxyl groups at multiple positions about the carbon backbone, allowing for a diverse array of possible structures. While additional substitution, including O-and C-methylation (Erlund, 2004) , prenylation (Stevens and Page, 2004) , gallation (Singh et al., 2011) , glucuronidation (Hegnauer and Gpayer-Barkmeijer, 1993) , and polymerization (Manach et al., 2004) at various positions about the backbone structure all also further expand the diversity of the flavonoid family, glycosylation is arguably the most significant single native structural feature in determining the pharmacokinetics of any flavonoid in the human diet. The addition of a sugar moiety is capable of fundamentally altering parent compound bioavailability following oral consumption by modulating critical physicochemical parameters such as structural polarity (Day et al., 2000) . Flavonoid glycosylation usually proceeds by the attachment of a sugar substituent to a hydroxyl group during in planta flavonoid synthesis, thus conferring O-glycosylation via preservation of the hydroxyl oxygen in the glycosidic linkage. Such a biochemically demanding reaction is assumed to be required in order to stabilize the receiving flavonoid, which subsequently exhibits the function of both the donor and receptor molecules in planta (Hultin, 2005) . This synthetic O-glycosylation reaction is catalyzed by a myriad of family-1 O-glycosyltransferases (OGTs) in the presence of nucleotide-diphospho-sugars (UDP-sugars) as substituent group donors participating in a final step during flavonoid synthesis (Lairson et al., 2008) . It is common for both the glycosylated and aglycone forms of the same parent flavonoid to be present in the same food crop, as in the example of the onion (Allium cepa). The edible onion bulb contains both the flavonol aglycone quercetin and its four Oglycosylated derivatives: rutin, quercetin 3-O-glucoside, 4 -Oglucoside, and 3,4 -O-diglucoside (Marotti and Piccaglia, 2002) . O-glycosylation most usually occurs on the aglycone flavonoid hydroxyl group at the 7 position of the flavonoid backbone, at the 3 position of flavonol structures, at the 4 position, and less frequently at other positions of hydroxylation (Ferreres et al., 2007) . The general system of flavonoid ring numbering is shown in Fig. 1 .
C-glycosyl flavonoids, the subject of this review, are a less well-understood subclass of secondary plant metabolites in comparison to their more common and structurally diverse Oglycosyl cousins. The defining feature and divergent characteristic of their formation and subsequent nature is a C-C covalent bond between the aglycone flavonoid backbone and a sugar moiety: generally monomer glucose or galactose. This linkage is found in dietary examples of C-glycosyl flavonoids at either the 6 or 8 positions about the carbon backbone A-ring, and differs from O-glycosyl examples in the limited number of glycosylation positions, the form and range of attached saccharide polymerization, and critically in the lack of an oxygen intermediate required for glycosidic linkage synthesis (Franz and Grun, 1983) . Another less common subclass are the O-glycosyl-Cglycosyl flavones, characterized by O-glycosylation at the same positions as described for mono-O-glycosyl flavonoids in addition to C-glycosylation elsewhere on the flavone backbone, or O-glycosylation at one of the hydroxyl groups of a C-linked sugar moiety. The latter form of O-glycosylation occurs most usually at the 2 or less frequently at the 6 carbon of a C-linked hexose sugar (Ferreres et al., 2007) .
It is likely that C-glycosylation usually occurs as an integral part of in planta flavonoid biosynthesis rather than as a final stabilizing step. In this regard, the lack of requirement for positional hydroxylation and the involvement of a separate synthetic pathway show that the biosynthetic process is distinct from that of O-glycosylation. This pathway has been investigated most thoroughly in wheat (Triticum aestivum), rice (Oryza sativa), and buckwheat (Fagopyrum esculentum). The principal reaction is catalyzed in these plants by the Cglycosyltransferase (CGT) family of enzymes, the best characterized of which is OsCGT: a 49 kDa enzyme related strongly in amino acid sequence to the known O-glycosyltransferases (Brazier-Hicks et al., 2009 ). More recently, aglycone flavan-3ol structures such as epicatechin have been shown to be nonenzymically mono-or di-C-glycosylated with glucose or galactose during postharvest processing, although as with OsCGTcatalyzed glycoconjugation, positions of substitution are limited to the hydroxyl groups at 6 and 8 positions (Stark and Hofmann, 2006) .
The significance of the C-glycosidic linkage to the overall flavonoid structure is greater than that which might at first be imagined in view of the seemingly relatively minor chemical divergence from the O-glycosidic linkage. The C-glycosidic bond between a saccharide moiety and flavonoid carbon skeleton largely protects the flavonoid glycoside from the hydrolytic effect of both acidic and enzymic treatments known to readily cleave O-glycosidic linkages, leading to fundamental differences in the analysis, degradation, pharmacokinetics, and bioactivity of those flavonoids possessing a C-glycosyl group (Harborne, 1965) . While C-glycosylation of flavonoid compounds in planta is not widespread, especially in those plants traditionally used as food crops, plants capable of C-glycosylation may produce C-glycosyl flavonoids in greater amounts than O-glycosyl flavonoids by weight, such as in the examples of the C-glycosyl flavones in wheat (Triticum aestivum) and Cglycosyl dihydrochalcones in rooibos tea leaves and stems (Aspalathus linearis) (Bramati et al., 2002; Brazier-Hicks et al., 2009) . As such, it is reasonable to suggest that these compounds deserve greater interest than previously has been afforded. Various plants produce a wide variety of C-glycosyl flavonoids in the leaves, however, the parts of such plants traditionally present in the human diet appear to contain a narrower range. In durum wheat (Triticum durum), for example, 29 Cglycosyl derivatives of apigenin, luteolin, and chrysoeriol, including some di-C-glycosides, have been identified in the leaves (Cavaliere et al., 2005) . In contrast, wheat grain is known to contain only five such compounds, four of which are derivatives of the flavone luteolin. Biosynthetic pathways in planta have been well characterized in certain species not traditionally included in the human diet, initially being studied in duckweed (Spirodela polyrhiza) (Wallace and Alston, 1966) . Even prior to this publication, other workers had reported the presence of Cglycosylated flavonoids in over 40 plant species. Harborne had also determined the hydrolytic fragility of over 100 flavonoid glycosides and glucuronides by both chemical (strongly acidic) and enzymic means, providing a comprehensive assessment of the conditions that could be easily employed to distinguish C-from O-glycosyl flavonoids (Harborne, 1965) . It was concluded that β-D-glucosidase glucohydrolase (β-glucosidase), an endogenous mammalian enzyme typically employed to nonspecifically deglycosylate O-glycosylated flavonoids in vitro, had no specificity to the C-glycosyl linkage. Hydrolytic attempts in acidic ethanol/water mixtures at 100 • C for 24 hours proved similarly ineffective. Thus a simple, specific, and robust analytical means of distinguishing this critical structural divergence in glycosyl flavonoids extracted from plant or crop materials was provided.
Known flavonoids found exhibiting native C-glycosylation in the human diet are limited to the flavones and dihydrochalcones, while C-glycosyl flavan-3-ols are known to be formed during food processing. A notable disparity exists between the structural nomenclature of the three-ringed flavones and flavan-3-ols and the two-ringed dihydrochalcones insofar as A-and B-ring carbon numerical priming is reversed (the flavone and flavan-3-ol B-ring is primed, while the dihydrochalcone A-ring is primed). The lack of a C-ring also dictates that dihydrochalcone A-ring numbering is offset by three fewer carbons about the phenolic ring in comparison to the flavone and flavan-3ol A-rings, as shown in Figs. 1-4. As with many O-glycosyl flavonoids, all known dietary C-glycosyl flavonoids possess a hydroxyl group at the 7 position on the flavonoid backbone Aring (or the equivalent 4 position on the dihydrochalcone structure). This group is often additionally O-glycosylated in planta, however, presumably as a downstream step in the flavonoid biosynthetic pathway. It seems likely that, while unglycosylated, this group confers substrate specificity to the CGTs, with equal potential of glycosylation at the 6 or 8 position (3 and 5 , respectively, for dihydrochalcones) through spontaneous rotation of the A-ring while in the open-ringed 2-hydroxyflavanone form during biosynthesis. These exist in equilibrium between open-chain and closed-chain (C-ringed) forms. Closed-chain forms are subsequently enzymically dehydrated, fixing the position of C-glycosylation in either the 6 or 8 A-ring positions of the flavone backbone (Brazier-Hicks et al., 2009 ). In many examples, C-glycosylation in one of these positions does not appear to prevent C-glycosylation of the other, nor does it prevent O-glycosylation at the 7 (dihydrochalcone 5 ) position.
NATURE AND DISTRIBUTION OF C-GLYCOSYL FLAVONOIDS IN THE HUMAN DIET
The most common sources of C-glycosylated flavonoids in the human diet are tomatoes, dates, lemons, limes, wheat, oats, maize, rice, buckwheat, rooibos tea, processed cacao, and Swiss chard, as summarized in Tables 1-4. While literature describing the distribution of these compounds in specific organs of the plant typically consumed as part of the human diet is limited in comparison to characterization in other parts (and in particular the leaves), even less data is available on the abundance or variation of these compounds in unprocessed crops, or indeed quantities of individual structures in the diet. Nevertheless, indications are provided where available.
Fruit
The flavonoids of tomato (Lycopersicon esculentum) fruits are generally confined to the skin, with little or no presence in the central flesh. In one study, chalconaringenin dominated the composition in the skins of nine cultivars quantified by HPLC-DAD (35-71%), however, the C-glycosyl dihydrochalcone phloretin 3 ,5 -di-C-β-D-glucoside was found to contribute 5-14% of the total flavonoid content and was present in all cultivars tested (Slimestad et al., 2008) . This is currently the only C-glycosyl flavonoid identified in tomatoes, and indeed is the first dihydrochalcone identified in genus Lycopersicon and family Solanaceae. It is unusual in the presence of two C-linked glucose substituent groups, both present on the A-ring (3 and 5 positions) of the dihydrochalcone backbone. It is possible, however, that the biosynthetic pathway of phloretin 3 ,5 -di-C-β-Dglucoside is a diversion from the formation of chalconaringenin, differing only in a single glycosyl group and the saturation of the α and β carbons (i.e., in the difference between chalcone and dihydrochalcone). Flavonoid C-glycosylation occurs in nature almost exclusively at either the 6 or 8 positions on the flavonoid A-ring. As such, phloretin 3 ,5 -di-C-β-glucopyranoside appears unusual in structure simply as a result of dihydrochalcone nomenclature (as previously discussed) rather than disposition. A di-C-glycosyl flavonoid is also present in the edible fruit of the Deglet Noor cultivar of the date palm (Phoenix dactylifera). The flavone apigenin 6,8-di-C-β-D-glucoside (vicenin-2) was identified by LC-MS/MS as the only C-glycosylated flavonoid alongside a variety of O-glycosyl flavonoids (Yun et al., 2006) .
Citrus Fruit
Vicenin-2 is also present in the lemon fruit (Citrus limon) (Gil-Izquierdo et al., 2003) , accompanied by three further dietary di-C-glycosylated flavonoid examples. The flavones diosmetin 6,8-di-C-β-D-glucoside (Miyake et al., 1997) , luteolin 6,8-di-C-β-D-glucoside (lucenin-2) (Baldi et al., 1995) , and chrysoeriol 6,8-di-C-β-D-glucoside (stellarin-2) (Garg et al., 2001) are present alongside two mono-C-glycosylated analogues, diosmetin 6-C-β-D-glucoside (Miyake et al., 1997) , and diosmetin 8-C-β-D-glucoside (Abad-Garcia et al., 2008) . Of all of these forms, only lucenin-2 in lemon fruit is partnered by its respective aglycone, luteolin (González-Molina et al., 2010) . This again serves to support the assertion that unlike O-glycosylated flavonoids, where aglycone and glycoside often coexist in the same source, C-glycosylation does not occur as the final reaction in the biosynthetic pathway. Lime (Citrus aurantifolia) fruits contain both diosmetin 6-and 6,8-di-C-β-D-glucoside, although these compounds are not found in other members of the citrus family (Caristi et al., 2006) . Vicenin-2 has also been shown to be present in freshly squeezed orange (Citrus sinensis) juice at 19.6 mg L −1 , and interestingly at the greater concentration of 26.3 mg L −1 in a commercially pasteurized juice (Gil-Izquierdo et al., 2001) . It is now clear that this phenomenon may be due to post-harvest C-glycosylation of apigenin in the presence of D-glucose and catalyzed by the heat of pasteurization, furthermore suggesting that mono-C-glucosyl apigenin derivatives such as vitexin may also be present.
Cereal Grains
The flavones of wheat (Triticum aestivum) grain were first discovered by King in 1962, who observed the presence of two flavones comprising 0.2-0.3% w/w dry-matter in commercial wheat germ samples (King, 1962) . UV spectral analysis after partial purification revealed these compounds to be 8-C-glycosyl apigenin derivatives, one of which was acylated with syringic acid. Characterization of the glycosidic substituent was reported to not be possible for these com-pounds, however, acylation of C-glycosyl apigenin derivatives with hydroxycinnamic acids has since been shown to be common in cereal grains, and can be circumvented during routine analysis by alkaline hydrolysis of the substituent moiety to release the glycosyl flavone from the phenolic acid ester (Ferreres et al., 2007) . The advent of tandem mass spectrometry has provided a useful tool in the detection and structural elucidation of the C-glycosyl flavonoids (Kazuno et al., 2005) , especially those found natively esterified or acylated. LC-MS/MS analyses of wheat and rye (Secale cereal) grains have shown the presence of vicenin-2, apigenin 6-Cβ-D-glucoside-8-C-arabinoside (schaftoside), and apigenin 6-C-arabinoside-8-C-β-D-glucoside (isoschaftoside) in both free and acylated forms, both being esterified with ferulic or synapic acid in the 6 position of the glucose moiety (Wagner et al., 1980; Gallardo et al., 2006) . Both schaftoside and its reverse-glycosylated isomer are the predominant flavonoids in hard red spring wheat bran (Feng and McDonald, 1987; , 1988, 2008) . Buckwheat (Fagopyrum esculentum) hulls contain the mono-C-glycosyl flavones orientin, isoorientin (luteolin 8-and 6-C-β-D-glucoside respectively), vitexin, and isovitexin (apigenin 8-and 6-C-β-D-glucoside respectively), whereas the groats (the commonly consumed fraction of the seed) contain only isovitexin (Watanabe, 1998; Dietrych-Szostak and Oleszek, 1999) . Significant quantities of vitexin have also been found in the flour of millet seeds (Pennisetum americanum), with reported amounts ranging between 77 and 275 mg g −1 (Akinbala, 1991) , while isovitexin is also present in rice hulls (Ramarathnam et al., 1989) . Barley grains contain nine O-glycosylated C-glycosyl flavonoids, in which both pathways of glycosylation are followed by the same compound during in planta biosynthesis, resulting in at least one of each O-and C-glycosyl substituent groups being present at separate positions on the aglycone flavonoid backbone (Ferreres et al., 2009). In barley grain, these are isoorientin- (Ferreres et al., 2009) . It is worth noting that this complex form of glycosylation differs to those equally complex but structurally divergent compounds containing an O-glycosidic linkage between the two hexose sugars of a C-linked disaccharide flavonoid subspecies that are present in the inedible leaves of plants such as barley (Ferreres et al., 2007) . Isoorientin is the only additionally identified mono-C-glycosyl flavonoid in barley seed (Ferreres et al., 2009) .
Edible Leaves and Stems
Chard (Beta vulgaris) leaves, commonly known as Swiss Chard, contain vitexin 2 -C-xyloside and vitexin 2 -C-[6malonyl]-xyloside: the only example of a dietary C-glycosyl flavonoid acylated with a dicarboxylic acid (Gil et al., 1998) . 
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Note: The (−)-epicatechin structure is defined in Fig. 3 . Glc, glucose; Gal, galactose.
These compounds were extracted with methanol from the leaf material to yield 1.39 and 0.34 mg g −1 undried leaf material, respectively. In a separate study, the edible stems of rhubarb (Rheum rhabarbarum), a relative of chard, were shown to contain isovitexin, vicenin-2, schaftoside, and isoschaftoside . Rooibos tea, a tisane produced from the leaves and thin stems of the rooibos plant (Aspalathus linearis), contains significant amounts of two examples of dietary C-glycosyl dihydrochalcones (Koeppen and Roux, 1966; Schmandke, 2005) . These unusual compounds have received a significant deal of attention, not least because of their abundance in this tisane and the importance of this principal South African export to its home economy. Indeed, the routine quantification of both aspalathin (2 ,3,4,4 ,6 -pentahydroxy-3-C-β-Dglucopyranosyldihydrochalcone) and the 2 ,4,4 ,6 tetrahydroxylated analogue, nothofagin, has become an accepted measure of rooibos quality, with several publications detailing methodologies for analysis and abundance in material from various processing yards and following several processing protocols (Rabe et al., 1994; Joubert, 1996; Joubert and deVilliers, 1997; vonGadow et al., 1997; Standley et al., 2001; Bramati et al., 2002 Bramati et al., , 2003 Schulz et al., 2003; Manley et al., 2006; Joubert et al., 2008; Pengilly et al., 2008) . The predominant factor determining the concentration of these two C-glycosyl dihydrochalcones in rooibos tea is the "fermentation" process. This comprises a heating and/or sundrying step (usually between 35-45 • C) that catalyzes the oxidation of phenolic compounds in the dried leaf and stem material (Joubert, 1996) . This process is responsible for the distinct red-color of both the tea material and resulting aqueous extract, and is best understood in the case of oxidative ring- 
Note: The (−)-catechin structure is defined in Fig. 4 . Glc, glucose; Gal, galactose.
cyclisation of aspalathin in the presence of heat or UV radiation and oxygen, a reaction that forms two additional closed-ring C-glycosylated eriodictyol products that, while not native to the rooibos plant, can be considered to be part of the fermented rooibos tisane (Marais et al., 2000) . A-ring cyclisation prior to closure and formation of a third C-ring dictates the formation of two isomeric C-glycosylated forms, eriodictyol-6-Cβ-D-glucoside and eriodictyol-8-C-β-D-glucoside, from the 8 C-glycosylated precursor aspalathin. Unfermented, freeze-dried rooibos tea therefore contains ∼ 14 times the total quantity of aspalathin (∼ 15 g kg −1 ) and presumably due to a similar oxidation reaction in production of the fermented product, 12 times the quantity of nothofagin (4.31 g kg −1 ) when compared to oxidized rooibos tea (1.02 and 0.35 g kg −1 , respectively) (Joubert, 1996) . This is an important factor in considering the dietary burden of the rooibos C-glycosyl dihydrochalcones, as both unfermented ("green") and fermented (often known as "redbush") rooibos tea is consumed. Rooibos also contains the flavones orientin and isoorientin, both native to the plant and derived from the pathway of aspalathin oxidation during fermentation via the two aforementioned eriodictyol-C-glucoside isomers (Rabe et al., 1994; Marais et al., 2000) . These isomeric compounds are reported to be interconvertable via a Wessely-Moser rearrangement of the flavone structure under heating in an aqueous solution: conditions similar to those that occur during tisane extraction (Koeppen and Roux, 1965) . They are extractable in hot aqueous media from commercial fermented rooibos tea at 1.00 and 0.83 g kg −1 , respectively; comparable to the aspalathin extracted in the same manner (1.23 g kg −1 ) (Bramati et al., 2002) . The flavones vitexin and isovitexin are also present in rooibos tea, however, are significantly less abundant than the aforementioned compounds (0.33 and 0.27 g kg −1 , respectively). Extraction of sugar from the stems of the sugarcane plant (Saccharum officinarum) is the first step in an extended process of refinement, the products of which are various forms of sugar-based products. During processing, a surprising array of flavonoids is found in the extracted juice and bagasse (the ligninbased material left after juice extraction), many of which are C-glycosylated. These include the dimethylated flavone 4 ,5dimethyl luteolin-8-C-β-D-glucoside, luteolin-8-C-rutinoside, vitexin, orientin, schaftoside, isoschaftoside, and diosmetin-8-C-β-D-glucoside (Colombo et al., 2006 (Colombo et al., , 2008 . While these compounds are easily detectable during processing, no data is currently available detailing flavonoid survival through further refinement to consumed products such as molasses or refined sucrose.
Synthesis during Cocoa Processing
The pH and temperature conditions often used in the postharvest processing of foods have been shown to catalyze the C-glycosylation of aglycone flavonoids. The only dietary example to date is the nonenzymatic formation of flavan-3-ol C-glycosides during cocoa tree (Theobroma cacao) seed processing during the production of chocolate, however, other theoretical structures have been synthesized in the laboratory and the chemistry of their production elucidated. (−)-Epicatechin-8-C-β-D-galactopyranoside was first evidenced in processed cocoa (Hatano et al., 2002) , followed by the 6-and 8-C-β-D-glucopyranosyl, 6,8-C-β-D-diglucopyranosyl and 6,8-C-β-D-digalactopyranosyl derivatives of (−)-epicatechin, summarized in Table 3 . (−)-Catechin-C-glycopyranosides have also been identified in cocoa, produced both as a product of the C-glycosylation reaction and in increasing amounts following alkalinization, presumably as a result of (−)-epicatechin-C-glycoside epimerization under basic conditions. These are the corresponding (−)-catechin epimers of the cocoa (−)-epicatechin C-glycosides alongside (−)-catechin-6-C-β-D-galactopyranoside (Stark and Hofmann, 2006; Stark et al., 2007) . Table 4 outlines these structures. In view of the universal commercial and domestic use of high temperature in the sterilization and preparation of food products, is highly likely that many untold C-glycosylated flavonoid species are formed as a result, and are, therefore, present in the human diet. Further research is required to elucidate the extent of their formation.
THE BIOLOGICAL FATE OF C-GLYCOSYL FLAVONOIDS IN THE HUMAN DIET
Deglycosylation has often been referred to as a critical step in the "activation" of flavonoids following human consumption (Hollman et al., 1999; Walle et al., 2005 ). This appears to be generally true for O-glycosylated compounds, as buccal, intestinal or colonic enzymic hydrolysis results in improved bioavailability of the resulting aglycone (Hollman and Katan, 1997; Day et al., 1998; Walle et al., 2005) , however, greater resistance of the C-glycosidic linkage to hydrolysis dictates that the bioavailability of C-linked flavonoid glycosides is somewhat different. Increasing evidence suggests that deglycosylation is not a prerequisite for C-glycosyl flavonoid absorption in the small intestine, resulting in the presence of the intact glycosyl flavonoid in the urine of humans following oral consumption. This phenomenon has been best characterized for the dietary C-glycosyl dihydrochalcone, aspalathin, intact urinary methyl metabolites of which were quantified in the human subjects of two separate studies following single-dose oral administration of similar aspalathin-rich rooibos tea beverages, and also in pigs fed high chronic doses of rooibos tea extract (Kreuz et al., 2008; Courts and Williamson, 2009; Stalmach et al., 2009 ). Interestingly, however, intact aspalathin metabolites were not detected in either human or porcine plasma in two of these studies, despite sensitive mass-spectrometric analysis; findings that are at odds with the common observation of circulating aglycone flavonoid metabolites in human plasma following ingestion of O-glycosyl flavonoids (Mullen et al., 2004) . The presence of intact aspalathin in urine suggests that the efficacy of existing plasma extraction protocols may not be suitable for the analysis of circulating C-glycosyl flavonoids, possibly due to the intact glucosylated structure having greater affinity for plasma carrier proteins such as serum albumin. This assertion is supported by the identification of intact puerarin, a nondietary Cglucosyl isoflavone from kudzu root (Pueraria lobata), in the plasma of humans, rats and dogs (Ma et al., 2005; Ren et al., 2006; Shen et al., 2007) . Despite these findings, the authors of a similar study reported the absence of C-glycosyl flavonoids in the collected urine or plasma of Sprague Dawley rats (n = 4) at any point in the 72 hours following a high, single-dose oral administration of 1 g kg −1 bamboo leaf extract in water (100 mg ml −1 ) containing the four flavone C-glycosides orientin, isoorientin, vitexin, and isovitexin. Similarly, none of these compounds were detected in the excised liver, brain, thigh muscle, and kidney tissue of these animals, prompting the authors to conclude that C-glycosyl flavones are not readily absorbed in the small intestine (Zhang et al., 2007) . In this case, it is highly likely that the HPLC-DAD methodology used for the analysis of these samples did not provide sufficient sensitivity in the detection of these compounds however, nor was provision made for the hydrolysis of metabolic conjugates prior to analysis of parent structures. Evidence from studies on the bioavailability of aspalathin, measured by the appearance of glucuronide and sulfate conjugates, suggests that like their aglycones, flavonoid C-glycosides are readily conjugated in vivo (Kreuz et al., 2008; Courts and Williamson, 2009; Stalmach et al., 2009 ). Furthermore, we have characterized the kinetics of catechol-O-methyltransferase (COMT)-catalyzed aspalathin Omethylation, showing that C-glycosyl flavonoids bearing a catechol moiety may also participate in this reaction. This was confirmed by the presence of 3-O-methylaspalathin in human urine following consumption of an aspalathin-rich beverage (Courts and Williamson, 2009 ).
Unpublished data from our laboratories suggest that aspalathin is capable of passive diffusion across the intestinal epithelium in transport studies using confluent filter-grown monolayers of the intestinal cell-line, caco-2. These monolayers were also found to be incapable of deglycosylating aspalathin during transepithelial flux, supporting data from human bioavailability studies. Moreover, enterocyte uptake of the intact C-glycoside in a similar model was negligible compared to the structurally similar dihydrochalcone O-glycoside, phlorizin, suggesting that bioavailability of the intact C-glycoside in humans is limited by nonspecificity to enterocyte glucose carrier proteins known to transport flavonoid O-glycosides, such as sodium-dependant glucose transporter 1 (SGLT-1) (Walgren et al., 2000) . Position of glycosylation and other structural features are known to affect substrate affinity of O-glycosyl flavonoids to these transporters however, providing a likely explanation for the lack of facilitated aspalathin diffusion, rather than nonspecificity of C-glycosidic linkages to glucose transporters.
Generally, O-glycosylated structures are not detected in vivo due to first-pass intestinal and hepatic hydrolysis, presumably catalyzed by broad-specificity β-glucosidases (Hays et al., 1996; Day et al., 1998 Day et al., , 2000 . C-Glycosyl flavonoids survive hepatic hydrolysis for reasons outlined previously, explaining their 1360 F. L. COURTS AND G. WILLIAMSON seemingly unusual presence in human urine following oral consumption (Courts and Williamson, 2009; Hasslauer et al., 2010) . As such, it is very likely that C-glycosylation does not confer diffusive flavonoid absorption per se, rather that the C-glycosyl bond of these compounds has greater stability in vivo.
While the C-glycosidic linkage appears to remain intact in the upper-and mid-gastrointestinal tract, and no known mammalian C-deglycosylating enzyme with specificity toward flavonoid structures exists, increasing evidence suggests that bacteria capable of cleaving the C-glycosidic linkage (putatively via expression of C-deglycosylating enzymes) are present in the colon, as outlined in Fig. 5 . Hasslauer et al. (2010) examined the respective difference in the ex vivo stability of (−)-epicatechin-6-C-glucoside in buffered human ileostomy and colostomy fluids at 37 • C for 10 hours (pH 6.3 and 7.4, respectively). No significant degradation occurred in ileostomy fluid, however complete degradation occurred following incubation for between 2 and 4 hours in colostomy fluid. Also reporting excellent stability in saliva and simulated gastric juice, the authors conclude that Cglycosyl flavan-3-ols undergo rapid degradation via microbial metabolism only in the human colon.
C-Deglycosylating enzymes from plants have already been identified, such as an example purified from safflour (Carthamus tinctorius), which was demonstrated to cleave the C-glycosyl linkage of orientin to yield its respective aglycone precursor, luteolin (Saito, 1990) . No such enzyme has yet been isolated from bacteria, however several studies have provided detailed information on the mechanism by which the colonic microflora may metabolize C-glycosyl flavones present in the lumenal milieu. Zhang et al. (2007) observed a decline in total C-glycosyl flavone presence in the total gastrointestinal contents of rats from 83 ± 1% at 30 minutes to 52 ± 1% at 12 hours following oral administration of a bamboo leaf extract containing orientin, isoorientin, vitexin, and isovitexin. This decline was not accompanied by the presence of these compounds in the urine or plasma of these animals, indicating that absorption was not wholly responsible for this effect, but was allied to increased concentrations of small aromatic products of microbial flavonoid metabolism. The four C-glycosyl flavones were shown to undergo significant deglycosylation in both dehydrogenated and native forms, with the former product being further metabolized by C-ring fissure to form small aromatic metabolites such as phloroglucinol, hydrocaffeic acid, and phloretic acid in the gastrointestinal tract (Zhang et al., 2007) . Similarly, human faecal preparations have been shown to catalyze the Cdeglycosylation of flavonoids. Braune and Blaut (2011) recently identified a strain of the colonic bacterium Lachnospiraceae (CG19-1) from human faecal suspensions capable of deglycosylating the dietary C-glycosyl flavones vitexin and isoorientin as well as mangiferin, a C-glycosyl xanthanoid from mango (Mangifera indica), and puerarin (daidzein 8-C-β-D-glucoside). This work confirmed and furthered the earlier findings of a number of authors, including Jin et al. (2008) , who isolated an uncharacterized strain of intestinal bacteria from human faecal cultures capable of deglycosylating puerarin by reductive cleavage. Unlike Lachnospiraceae CG19-1, however, this unidentified strain demonstrated high specificity toward puerarin, and was unable to deglycosylate a number of other natural cyclic C-glycosylated structures, including mangiferin. A Bacteroides species (sp. MANG) isolated from human faecal cultures has also been shown to deglycosylate mangiferin, producing norathyriol. Interestingly, the C-deglycosylating activity was induced by the presence of this xanthanoid (yet native Odeglycosylating activity was unaffected) and was not prevented by glucosidase inhibitors such as gluconolactone. The authors cite these findings as evidence that the enzyme or enzyme system responsible for C-deglycosylation in the colon expressed by this bacterium may differ significantly from those capable of O-deglycosylation (Sanugul et al., 2005) .
KNOWN BIOLOGICAL ACTIVITIES OF DIETARY C-GLYCOSYL FLAVONOIDS
The majority of studies concerning C-glycosyl flavonoid bioactivity are principally derived from ethnopharmacological investigations detailing biological modulation and protective effects of plant extracts in cell and animal models. This approach traditionally focuses on the activity of broad plant-derived chemical mixtures, some of which are rich in C-glycosyl flavonoids. While it is tempting to include these examples in a review of the activities of such compounds, it is neither useful nor efficient to do so where no attempt has been made to ascribe the defined effect to a particular compound, as structure-function correlations are broadly masked by confounding unknowns in these extracts. As such, this review will principally focus on literature describing the defined bioactivities of enriched or purified C-glycosyl flavonoid fractions only. Additionally, direct antioxidant effects described in vitro will be omitted due to the lack of significant correlation between in vitro antioxidant capacity and in vivo plasma antioxidant capacity for some tested C-glycosyl flavonoids (Mladenka et al., 2010; Breiter et al., 2011; Hollman et al., 2011) .
Antidiabetic Activity
Interest surrounding the ability of C-glycosyl flavonoids to modulate glucose tolerance presumably stems from the hy-pothesized preservation of the glycosyl moiety in vivo, due to its aforementioned stable carbon-carbon glycosyl linkage (Harborne, 1965) . Studies concerning the antidiabetic properties of these compounds have focused primarily on the modulation of glucose uptake by the key glycogen storage organs (i.e., muscle and liver tissue) and the independent effects on insulin secretion by pancreatic β-cells. These effects were individually characterized in cell cultures in vitro by Kawano et al. (2009) . RIN-5F cells were used as a model of pancreatic β-cells, incubated with or without the C-glycosyl dihydrochalcone aspalathin at 100 μM for 3 hours. Insulin secretion was found to have increased by 30% over this time with no increase in cytotoxicity, however, in view of the low bioavailability of aspalathin the concentration of aspalathin required to elicit this effect appears biologically irrelevant (Kreuz et al., 2008; Courts and Williamson, 2009; Stalmach et al., 2009) . L6 rat myotubes were also cultured to determine the modulation of glucose uptake in muscle cells in the presence of aspalathin. Uptake of glucose (11 mM) present in the culture media was determined by the rate of myocyte-mediated glucose depletion over a 4-hour time-course. In this experiment, the aspalathin concentration required to produce an effect was significantly lower than in the insulin secretion study. Glucose uptake was increased by 24% at 1 μM, and 64% at 10 μM aspalathin (n = 6, p ≤ 0.05).
The combined significance of these findings can be validated in animal models through an oral glucose tolerance test, useful in determining how a fixed dietary glucose load is tolerated by an animal through the measurement of plasma glucose in response to the loading. Chronic or acute doses of a proposed modulating substance are added to the system in experimental groups to observe the change in tolerance of the animal to the acute glucose dose. Two recent studies have defined the specific effects of orally administered dietary C-glycosyl flavonoids in rodent models of diabetes. Folador et al. (2010) showed the improvement in glucose tolerance following single, acute doses of enriched fractions and isolated compounds from the roots of Taiuiá (Wilbrandia ebracteata), a nondietary Brazilian-native crop that contains swertisin, isoswertisin, vitexin, isovitexin, spinosin, orientin, and isoorientin. A butanolic fraction possessed the greatest activity in minimizing blood glucose elevation in a Wistar rat model of hyperglycemia generated through the administration of 4 g kg −1 oral glucose to fasted animals via gavage, and compared to a fasted euglycaemic control (nil oral glucose) cohort. Both isovitexin and swertisin were partially purified from the butanolic fraction and identified as the two principal compounds involved in this effect. Both C-glycosyl flavones were active, significantly reducing hyperglycaemia by 18% at a dose of 15 mg kg −1 after 30 minutes (n = 6, p ≤ 0.05). The relevance of this result to the human diet is again limited, however, due to the high dose used in this study, and therefore may, in turn, explain a lack of evidence for such an effect in humans.
Isovitexin was also shown to be active in improving the insulin response after glucose administration, although no isovitexin control in the euglycaemic group was monitored. As such, it is uncertain whether effect of isovitexin in this study is simply to nonselectively enhance insulin secretion independently of blood glucose concentrations, or whether it is capable of enhancing glucose sensitivity, improving the overall insulinemic response. Nevertheless, the response in isovitexin-treated animals occurred after 60-minutes' time-course of the experiment, thus improving serum insulin concentrations by 58% (n = 6, p ≤ 0.05). In agreement with this finding, the glycogen content of the soleus muscle in the same hyperglycaemic animals treated with isovitexin was 27% greater than the hyperglycaemic control (n = 6, p ≤ 0.05) (Folador et al., 2010) . Kawano et al. (2009) demonstrated the effects of chronic oral aspalathin intake on a bd/bd male mouse model of progressive hyperglycemia. Glucose was administered to the fasted animals by oral gavage, and serum glucose concentrations measured after 2 hours. Six control animals at four weeks' age were provided a standard diet containing no aspalathin as a model of type-2 diabetes, while a matched test cohort (n = 4) was provided an identical diet with the addition of 0.2% w/w aspalathin. No difference was observed in food intake. An almost linear serum glucose concentration increase was shown in control db/db animals over the five-week duration of the experiment, while a significantly lower increase was observed in the aspalathin-fed animals (n = 4, p ≤ 0.05). Prior to the experiment, both groups had blood glucose concentrations of 1.4 g L −1 , however, aspalathin-fed animals only increased to 4.25 g L −1 ; 70% of the control increase to 5.5 g L −1 glucose (Kawano et al., 2009) .
It is possible that the mechanism, by which these effects are potentiated, is via modulation of one or all of the hexokinase isoforms present in the pancreatic β-cells. The low expression of these enzymes in this cell-type allows (under normal conditions) for sensitive detection of blood glucose, as high expression of the glucose transporter GLUT-2 allows for extracellular glucose to closely relate to intracellular concentrations. The rate of hexokinase-catalyzed glucose phosphorylation is, therefore, closely related to the rate of insulin release (Schuit et al., 2001) . Provided the proposed flavonoid was bioavailable, it is possible that the intact glucose moiety may interact in this pathway, acting as a glucose-type ligand, up-regulating the glycaemic response.
Antiinflammatory Activity
Literature detailing the antiinflammatory effects of Cglycosyl flavonoids has only recently emerged, primarily focusing on vicenin-2. dos Santos et al. (2010) used the U-937 macrophage model to study the antiinflammatory effects of the medicinal plant Lychnophora ericoides. Macrophage stimulation with lipopolysaccharide (LPS) was used to generate a controlled immune response, measured by the production of the two inflammatory biomarkers, tumor necrosis factor (TNF) -α and prostaglandin (PG) E-2. Vicenin-2 derived from Lychnophora ericoides had a dose-dependent effect on PG E-2 without varia-tion in the expression of cyclooxygenase (COX) -2, the enzyme responsible for prostaglandin synthesis. TNF-α production was unchanged by vicenin-2 in this study, however, the work of Shie et al. (2010) showed this C-glycosyl apigenin-derivative among other synthetic examples to inhibit TNF-α expression in LPSactivated Raw264.7 mouse monocyte macrophages (IC 50 6.8 ± 2.5 μM). Nitric oxide release as part of the macrophage respiratory burst was also inhibited by viceinin-2 with an IC 50 of 3.9 ± 0.9 μM.
Vicenin-2 was also recently evaluated alongside vitexin for its role in the antinociceptive effects of the medicinal plant, Urtica circularis, in inflammation. Intraperitoneal injection of 10 mg kg −1 body-weight vitexin produced a 91% reduction in nociception induced by intraperitoneal injection of 1% acetic acid at 10 μL g −1 body weight in mice versus an untreated control, as measured by the number of abdominal writhes over the duration of the study (n = 5). The effect of this C-glycosyl flavonoid was in excess of the antiinflammatory pharmaceutical indomethecin, a positive control administered at the same concentration as the flavonoid candidates that nonselectively inhibits the COX family of enzymes (62%). Vicenin-2 also produced antinociceptive effects, the number of writhes being 41% lower than the control, supporting the COX-2 inhibitory data of dos Santos et al. (2010) (Gorzalczany et al., 2011 ). De Melo et al. (2005 have also shown the activity of both schaftoside and vitexin toward preventing neutrophil influx in a mouse model of lung inflammation induced by inhalation of aerosolized LPS at interperitoneally injected amounts of 400 μg kg −1 body-weight, with inhibition of 62% and 80% of control influx, respectively.
Neutrophil release of hyperchlorous acid (HOCl 2 ) and hydrogen peroxide (H 2 O 2 ) during the inflammatory "respiratory burst" response to an alien agonist occurs through myeloperoxidase (MPO) activity. Quílez et al. (2010) showed that an ethanolic subfraction of Piper carpunya containing the Cglycosyl flavones vitexin, isovitexin, rhamnopyranosylvitexin, and isoembigenin significantly reduced MPO activity to 48.2% of a control in an in vitro cosuspension of polymorphic nuclear leukocytes (PMNs) and mononuclear cells isolated from male Wistar rats at 50 μg mL −1 (p ≤ 0.001, n = 3). While activity was measured by the oxidation rate of O-dianisidine in the flavonoid-containing media over time and, therefore, may be due to the direct radical-scavenging activity of the flavonoid structure in this in vitro system, Zucolotto et al. (2009) also showed the MPO inhibitory activity of 25 mL kg −1 body weight interperitoneally injected isoorientin in vivo in a carrageenaninduced mouse model of the lung disorder, pleurisy (p ≤ 0.05, n = 3).
Anxiolytic Effects
Passiflora is a large genus of tropical flowering plants that, while not typical components of the human diet themselves (although are used for juice production in Brazil), contain many of the C-glycosyl flavones found in dietary sources. Sena et al. (2009) uniquely attempted to ascribe some of the reported anxiolytic effects of various extracts of this genus to these flavones. Extracts were administered by intragastric cannula and effects on the performance of three-month-old Swiss mice in a lightdark transition (LDT) were observed. A butanolic extract containing a high concentration of isoorientin, vicenin-2, 6,8-di-C-glycosyl chrysin, and spinosin administered at 25, 50, and 100 mg kg −1 body weight all produced a significant decrease in baseline anxiety as measured by an increase in time spent in the light compartment of the LDT test (p ≤ 0.01), mimicking the effects of the positive control, diazepam. This extract also significantly increased the number of transitions between the light and dark compartments of the test apparatus (p ≤ 0.01). Interestingly, an aqueous extract containing only isoorientin did not produce such effects versus the untreated controls. Isoorientin alone therefore had no anxiolytic effects in this experiment, however, both extracts also containing vicenin-2, 6,8-di-C-glycosyl chrysin, and spinosin appeared to improve baseline anxiety in the mouse model. This data are supported by the earlier work of Dhawan et al. (2001) , eliminating chrysin, apigenin, quercetin, hesperidin, and orientin as candidate mediators of this effect by adopting a progressive fractionation of Passiflora incarnata to isolate a fraction found to elicit the greatest anxiolytic activity using an elevated plus-maze model of anxiety in Swiss mice. The final fraction contained β-sitosterol and a single unidentified flavone (Dhawan et al., 2001) , which may, therefore, be either vicenin-2 or spinosin.
Antispasmodic Effects
Two studies have demonstrated the antispasmodic effects of C-glycosyl flavonoids from nondietary herbal extracts on tissues from rodents. Both studies used similar force transducer apparatus to monitor the responses of isolated segments of various tissues after treatment with isolated compounds ex vivo, leading to the attribution of effect to a C-glycosyl flavonoid in both cases. Afifi et al. (1999) treated isolated rat aorta, ileum, trachea, uterus, and guinea-pig uterus with orientin purified from Arum palaestinum. Despite previous work by Abdalla et al. (1994) showing the antispasmodic effect of the orientin aglycone, luteolin, on spontaneously contracting illeal tissue, and epinephrine or carbachol-induced aortic and tracheal tissue contraction, addition of the 8-C-glycosyl group appeared to abolish the activity of this flavone toward these tissues in this study. However, the amplitude of spontaneous contraction of both rat and guinea-pig uterus tissue was diminished through treatment with a range of orientin concentrations between 100 nM and 600 μM, giving IC 50 values of 205 ± 99 μM in rat tissue (n = 7) and 57 ± 20 μM in guinea-pig tissue (n = 8). The frequency of muscular contraction was also attenuated in a dose-dependent manner (Afifi et al., 1999) . Ragone et al. (2007) provided greater mechanistic evidence for effect of the dietary C-glycosyl flavone vitexin, but not its isomer isovitexin, isolated from the herbal plant Aloysia citriodora on attenuating induced rat duodenum contraction. Both acetylcholine and Ca 2+ dose-response curves were employed to potentiate contraction of the smooth muscle within this tissue. Increasing extracellular Ca 2+ concentrations caused a dosedependent extracellular release of acetylcholine, which has the downstream effect of polarizing the muscle fiber and eventually causing a contractile response. While both agonists play different but dose-dependent roles in the same pathway of contraction, the use of a dose-response curve to both of these reagents allows mechanistic elucidation of flavonoid effect mediation. Vitexin noncompetitively inhibited the acetylcholine dose-response to give a maximal inhibition of 69.4 ± 0.9 μM at 48.6 ± 12.0% of the E max of acetylcholine (n = 5). However, isovitexin, the 6-Cglycosylated isomer of vitexin, had no significant activity on the effect of acetylcholine at 69 μM (81.4 ± 9.5% of E max of acetylcholine), indicating that the position of C-glycosylation may be crucial in producing this effect. Interestingly, despite the crude extract of Aloysia citriodora from which these compounds were isolated being capable of so doing, neither compound had a significant effect on the tissue response to increasing extracellular Ca 2+ concentrations at 46.3 μM (Ragone et al., 2007) . Vitexin, therefore, has been shown to noncompetitively inhibit the activity of acetylcholine in potentiating smooth muscle contraction in rat duodenum, thus demonstrating its capability to produce a significant antispasmodic effect in the gastrointestinal tract at a high but lumenally relevant concentration (69.4 μM).
Hepatoprotection
Despite intriguing evidence of efficacy, the hepatoprotective effects of specific C-glycosyl flavonoids have been little studied. Hoffmann-Bohm et al. (1992) first discussed the important correlation between the position of flavonoid C-glycosylation and hepatoprotective effects in vitro. Extracts of Allophyllus edulis, a Paraguayan herb traditionally used in the treatment of jaundice, was studied in a carbon tetrachloride (CCl 4 ) model of hepatic damage using cultured primary rat hepatocytes. Isolated 8-C-glycosylated flavones (vitexin and orientin) from these extracts showed hepatotoxic effects, while the 6-C-glycosylated flavone isovitexin protected the hepatocyte culture following CCl 4 treatment. Further investigation revealed that addition of a rhamnose group to the existing C-glycosidic moiety reversed the effect of the 8-C-glycosides. The effect of isovitexin was also enhanced by substitution at the free 7-hydroxyl group, in this case by an O-methyl or O-glucosyl moiety.
This structure-function information is in agreement with the in vitro study of Orhan et al. (2003) , investigating the effects of phenolic compounds from the Turkish folk remedial herb Gentiana olivieri, including the 6-C-glycosyl flavone isoorientin, on single dose CCl 4 -induced liver damage in Sprague-Dawley rats. Subacute oral administration of 15 mg kg −1 body-weight isoorientin in 0.5% aqueous carboxymethyl cellulose (CMC) occurred daily for five days prior to a single dose of 50%
(v/v) CCl 4 in liquid paraffin at 2.5 mL kg −1 body-weight to induce liver damage, and samples were harvested for analysis 60 minutes following CCl 4 administration. Isoorientin appeared to normalize liver tissue malondialdehyde (MDA) compared to a negative control group that did not undergo CCl 4 treatment but was fed only blank CMC (control, 341.9 ± 13.6 nmol g −1 ; isoorientin treated, 340.4 ± 17.5 nmol g −1 ). MDA concentrations were found to be significantly improved in both of these groups in comparison to a positive control group that underwent CCl 4 treatment and was fed blank CMC (578.0 ± 39.5 nmol g −1 , p ≤ 0.01, n = 6). Accordingly, plasma MDA concentrations were also significantly decreased in the isoorientintreated cohort versus the positive control, although modulation did not reach the control baseline in this case (p ≤ 0.01, n = 6). Hepatic glutathione GSH concentrations also remained at the level of the control after isoorientin treatment (control, 15.3 ± 1.3 μmol g −1 ; isoorientin treated, 17.1 ± 1.2 μmol g −1 ), again giving significance versus the positive control (6.2 ± 1.2 μmol g −1 , p ≤ 0.001, n = 6). Transaminase markers of liver function were also improved to −75% and −80% of the positive control, respectively (p ≤ 0.001, n = 6). Taken together, these data indicate a significant decrease in oxidative stress in vivo, possibly via reduction in trichloromethyl radical generation, the major mechanism of hepatic damage following CCl 4 administration. Hepatic histological examination revealed that many parameters were unchanged between the control and isoorientin-treated animals, whereas severe or moderate damage was observed in the positive control. Indeed, central vein and sinusoid congestion were both improved by isoorientin-treated animals versus the untreated control group. Interestingly however, isoorientin treatment did not decrease the mild lymphocyte infiltration or Kupffer cell proliferation observed in the positive control group.
Despite the conclusion of these authors to the contrary, the remarkably diverse hepatic effects of structurally similar Cglycosyl flavones suggest that radical scavenging is not a primary mechanism of activity in the two studies outlined here. This is an assertion that is supported by the poor predicted bioavailability of these compounds, discussed in Section 3. Snijman et al. (2007) demonstrated the moderate antimutagenic effects of isolated C-glycosyl flavonoids from rooibos tea. Two model systems were employed to study the inhibition or stimulation of mutagenicity in metabolically activated tester strains Salmonella typhimurium TA98 and TA100 induced by 2acetamido-fluorene (2-AAF) and aflatoxin B 1 (AFB 1 ), respectively. The C-glycosylated flavonoids tested were aspalathin, nothofagin, orientin, isoorientin, vitexin, and isovitexin. With the exceptions of vitexin and isovitexin, all compounds exhibited antimutagenic effects in both systems. Isovitexin (0.8 mM) showed a significant 17 ± 10% increase in the mutagenic response of T98 to 2-AAF compared to an untreated control, as measured by the number of His + revertants (i.e., the number of mutants reverting back to the previous genotype) (p ≤ 0.05, n = 5). This was in stark contrast to the antimutagenic effect of the same compound in the T100 tester strain following AFB 1 treatment. A significant dose-dependent response was recorded, with a 0.8 mM concentration giving a 62 ± 5% relative reduction in revertant numbers, falling to 50 ± 3% at 0.4 mM and 37 ± 4% at 0.08 mM (p ≤ 0.05, n = 5). Nothofagin presented a similar dose-dependent profile of antimutagenicity toward AFB 1 in this assay (59 ± 3% at 0.8 mM), and while a shallower curve of effect was observed, the nothofagin analogue aspalathin gave a similar low-concentration effect at 0.08 mM (aspalathin, 33 ± 3%; nothofagin, 33 ± 8%, N.S.). The antimutagenic effects of these C-glycosyl dihydrochalcones also were demonstrated in the T98: 2-AAF model, however, as with orientin and isoorientin, a lack of dose-response was observed. These two isomeric flavones also exhibited a similar pattern of antimutagenicity in the T100: AFB 1 assay to the vitexin isomers (orientin, 59 ± 3%; vitexin, 51 ± 4%; isoorientin, 66 ± 10%; isovitexin 62 ± 5% at 0.8 mM).
Other Biological Effects
A human umbilical vein endothelial cell (HUVEC) line was cultured by Miyake et al. (1997) to study the effects of two di-Cglycosyl flavones, diosmetin 6,8-di-C-glucoside, and vicenin-2, isolated from citrus fruit, on inter-cellular adhesion molecule-1 (ICAM-1) expression after stimulation by TNF-α (10 ng mL −1 ). ICAM-1 is a cell-adhesion protein expressed on the surface of endothelial and immune system cells, allowing for the adhesion of these two cell types, a process that precedes migration of the immune cell (i.e., leukocyte) into the endothelium. Overexpression of this protein has, however, been associated with atherosclerotic lesion and plaque formation. While 10 μM diosmetin 6,8-di-C-glucoside had no significant effect on the expression of ICAM-1, vicenin-2 demonstrated a significant reduction at this concentration (85 ± 3% activity versus control, p ≤ 0.05, n = 4), although a lower concentration (1 μM) had no significant effect.
CONCLUSIONS
The C-glycosyl flavonoids have received little concerted attention in the literature with regard to human nutrition, as the majority of data relating to biological activity arises from ethnopharmacological investigations of various traditional medicinal plants. This lack of consideration from a nutritional standpoint does not appear to reflect the potential of this interesting class of compounds from the diet to confer novel biological effects, as the hydrolysis-resistant C-glycosidic linkage appears to uniquely result in the circulation of intact glycosyl flavonoids in vivo. The influence of an intact glycosyl moiety on the bioactivity of a given polyphenolic structure in vivo, therefore, requires much further consideration. No attempt has yet been made to separate highly-diverse known biological effects of aglycone flavonoids from those exhibiting C-glycosylation, however, in view of the biological significance of hexose sugars, the potential for intact glycosylated flavonoids to confer biological effects via this putative pharmacophore appears substantial. The true significance may only be truly elucidated by employing matched aglycone and C-glycosylated standards in all investigations where practicable. This is becoming an increasingly possibility with the commercial availability of an ever-expanding range of diverse phytochemicals and the publication of a relatively simple chemical means by which aglycone polyphenols may be efficiently C-glycosylated (Stark et al., 2007; Hasslauer et al., 2010) . Further pharmacokinetic studies are also required for these compounds, as limited data suggest low bioavailability, likely by virtue of the intact glycosyl group. 
